Satellos Bioscience Inc.
MSCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $8 | $25 |
| - Cash | $58 | $22 | $2 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$58 | -$22 | $6 | $20 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$8 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$11 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.18 | -0.32 | -0.64 |
| % Growth | -33.3% | 43.8% | 50% | – |
| Operating Cash Flow | -$25 | -$15 | -$6 | -$5 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$25 | -$15 | -$6 | -$5 |